The effects of hyperprolactinemia and its control on metabolic diseases.

Renata S AuriemmaDario De AlcubierreRosa PirchioRosario PivonelloAnnamaria Colao

Published in: Expert review of endocrinology & metabolism (2018)

Hyperprolactinemia promotes metabolic alterations. Control of PRL excess by dopamine agonists is mandatory to induce weight loss and to improve metabolic profile, and replacement treatment for concomitant hypogonadism effectively ameliorates insulin resistance and metabolic syndrome.

Keyphrases

metabolic syndrome
insulin resistance
weight loss
uric acid
type diabetes
adipose tissue
high fat diet
cardiovascular disease
high fat diet induced
weight gain
glycemic control